Livestreaming Platform Supported by:

custom image custom image custom image custom image

  0      0

33rd Annual North American Cystic Fibrosis Conference

S04--INF/MIC-NT: Bacteriophage Therapy for Airway Infection: What is the Potential for CF?

Oct 31, 2019 2:00pm ‐ Oct 31, 2019 3:45pm


This session will explore the potential for bacteriophage therapy as an anti-bacterial therapy for airway infection in CF. The session will include three presentations that will focus on (i) the fundamentals of bacteriophage biology, (ii) a brief history of the use of bacteriophages as anti-infective therapy in humans, and (iii) potential obstacles to the use of bacteriophage therapy in CF.

Learning Objectives:

  • Review the basics of bacteriophage biology and ecology with respect to their antibacterial activity.   
  • Describe the history of bacteriophages as antibacterial therapy for human infection. 
  • Summarize the potential obstacles that challenge the use of bacteriophages for therapy of airway infection in CF.

Symposium Chair(s):

Symposium Speaker(s):

You must be logged in and own this session in order to post comments.